Bicara Therapeutics (BCAX) Institutional Ownership $19.12 +0.37 (+1.97%) (As of 01:00 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Bicara Therapeutics (NASDAQ:BCAX)Number ofInstitutional Buyers(last 12 months)22TotalInstitutional Inflows(last 12 months)$396.56MNumber ofInstitutional Sellers(last 12 months)0 Get BCAX Insider Trade Alerts Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BCAX Institutional Buying and Selling by Quarter Ad DarwinHow Low-Cost Stocks Generate Monthly IncomeAre you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 Bicara Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC10,000$255K0.0%N/A0.018% 11/18/2024 Teachers Retirement System of The State of Kentucky14,039$358K0.0%N/A0.026% 11/16/2024 Geode Capital Management LLC48,639$1.24M0.0%N/A0.094% 11/15/2024 Barclays PLC10,000$255K0.0%N/A0.019% 11/15/2024 Jane Street Group LLC12,151$309K0.0%N/A0.023% 11/15/2024 Wellington Management Group LLP763,943$19.46M0.0%N/A1.476% 11/15/2024 Soros Fund Management LLC20,000$509K0.0%N/A0.039% 11/15/2024 Samsara BioCapital LLC35,000$891K0.2%N/A0.068% 11/15/2024 RA Capital Management L.P.6,955,993$177.17M2.0%N/A13.439% 11/15/2024 Point72 DIFC Ltd55,757$1.42M0.0%N/A0.108% 11/15/2024 Point72 Asset Management L.P.371,962$9.47M0.0%N/A0.719% 11/15/2024 Maven Securities LTD50,000$1.27M0.0%N/A0.097% 11/15/2024 Iron Triangle Partners LP200,000$5.09M0.7%N/A0.386% 11/15/2024 Janus Henderson Group PLC1,188,191$30.33M0.0%N/A2.296% 11/15/2024 Cinctive Capital Management LP9,001$229K0.0%N/A0.017% 11/15/2024 Baker BROS. Advisors LP833,333$21.23M0.2%N/A1.610% 11/15/2024 Point72 Asia Singapore Pte. Ltd.18,125$462K0.1%N/A0.035% 11/14/2024 Braidwell LP1,657,600$42.22M1.2%N/A3.202% 11/14/2024 Vestal Point Capital LP425,000$10.83M0.8%N/A0.821% 11/14/2024 Walleye Capital LLC31,780$809K0.0%N/A0.061% 11/13/2024 FMR LLC2,273,792$57.91M0.0%N/A4.393% 11/13/2024 The Manufacturers Life Insurance Company22,859$582K0.0%N/A0.044% 11/7/2024 First Turn Management LLC562,391$14.32M2.3%N/A1.087% (Data available from 1/1/2016 forward) BCAX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCAX shares? During the previous two years, 22 institutional investors and hedge funds held shares of Bicara Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($177.17M), FMR LLC ($57.91M), Braidwell LP ($42.22M), Janus Henderson Group PLC ($30.33M), Baker BROS. Advisors LP ($21.23M), Wellington Management Group LLP ($19.46M), and First Turn Management LLC ($14.32M).Learn more on BCAX's institutional investors. Which institutional investors have been buying Bicara Therapeutics stock? Of the 22 institutional investors that purchased Bicara Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.96M), FMR LLC ($2.27M), Braidwell LP ($1.66M), Janus Henderson Group PLC ($1.19M), Baker BROS. Advisors LP ($833.33K), Wellington Management Group LLP ($763.94K), and First Turn Management LLC ($562.39K). How much institutional buying is happening at Bicara Therapeutics? Institutional investors have bought a total of 15,569,556 shares in the last 24 months. This purchase volume represents approximately $396.56M in transactions. Related Companies OGN Institutional Ownership PTCT Institutional Ownership VRNA Institutional Ownership RYTM Institutional Ownership MLTX Institutional Ownership EWTX Institutional Ownership JANX Institutional Ownership XENE Institutional Ownership MRUS Institutional Ownership ACAD Institutional Ownership This page (NASDAQ:BCAX) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicara Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCAX Stock Alerts